Streamline Health Solutions (NASDAQ:STRM) Now Covered by StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note issued on Wednesday. The brokerage set a “sell” rating on the stock.

Streamline Health Solutions Trading Down 6.3 %

NASDAQ STRM opened at $0.89 on Wednesday. Streamline Health Solutions has a fifty-two week low of $0.80 and a fifty-two week high of $2.35. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.80 and a current ratio of 0.80. The stock has a 50 day simple moving average of $1.22 and a two-hundred day simple moving average of $1.50. The stock has a market cap of $52.25 million, a P/E ratio of -3.86 and a beta of 1.27.

Streamline Health Solutions (NASDAQ:STRM) last released its quarterly earnings data on Wednesday, September 13th. The company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.02. Streamline Health Solutions had a negative return on equity of 35.03% and a negative net margin of 47.32%. The business had revenue of $5.77 million during the quarter.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in STRM. Prudential Financial Inc. bought a new position in shares of Streamline Health Solutions in the 2nd quarter worth approximately $31,000. BerganKDV Wealth Management LLC bought a new position in shares of Streamline Health Solutions in the 2nd quarter worth approximately $32,000. HRT Financial LP bought a new position in shares of Streamline Health Solutions in the 4th quarter worth approximately $34,000. Dfpg Investments LLC raised its position in shares of Streamline Health Solutions by 146.9% in the 1st quarter. Dfpg Investments LLC now owns 27,272 shares of the company’s stock worth $49,000 after acquiring an additional 16,224 shares in the last quarter. Finally, Morgan Stanley raised its position in shares of Streamline Health Solutions by 3,400,000.0% in the 4th quarter. Morgan Stanley now owns 34,001 shares of the company’s stock worth $54,000 after acquiring an additional 34,000 shares in the last quarter. Institutional investors own 34.60% of the company’s stock.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.